跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TISSEEL KIT VH 1.0 - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TISSEEL KIT VH 1.0
Authorized
STANDARD
TISSEEL KIT VH 1.0
Baxter AG
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
74bc0112c2fbaef4
Company
Baxter AG
Type
Standard
Approval Details
Approval Id
74bc0112c2fbaef4
Drug Approval Canada Name
TISSEEL KIT VH 1.0
Product Name
TISSEEL KIT VH 1.0
Status
Cancelled Post Market
Status Date
2014-06-10
Original Market Date
1998-10-13
Din
02233273
Drug Class
Human
Dosage Form
Kit , Liquid , Powder For Solution
Route Of Administration
Topical
Schedule
Schedule D , Prescription
Ahfs
20:28.16
Atc Original
B02BD20 COMBINATIONS
Atc Name
b 02 bd 20
Aig Number
0936991008
Company Name
Baxter AG
Company Address
Industriestrasse 67, Vienna, Saone Et Loire, Austria, 1220
Company Detail Path
/organization/baxter-ag
Company Information
Pharmaceutical Company Name
Baxter AG
Country Name
Switzerland
Province Name
Zürich
City Name
glattpark (opfikon),zürich,country_ch
Address
Thurgauerstrasse 130
Website
http://www.baxter.ch
Active Ingredients
APROTININ (BOVINE)
3000 KIU / 1 ML
FACTOR XIII
50 UNIT / 1 ML
CALCIUM CHLORIDE
40 MCMOL / 1 ML
FIBRINOGEN (HUMAN)
110 MG / 1 ML
PLASMINOGEN
120 MCG / 1 ML
THROMBIN (HUMAN)
4 UNIT / 1 ML
THROMBIN (HUMAN)
500 UNIT / 1 ML
PLASMAFIBRONECTIN (CIG)
9 MG / 1 ML
TOTAL PROTEIN
130 MG / 1 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
74bc0112c2fbaef4
Type
Standard
Back to Health Canada Approvals